Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.490
+0.020 (1.36%)
At close: May 29, 2026, 4:00 PM EDT
1.480
-0.010 (-0.67%)
Pre-market: Jun 1, 2026, 8:22 AM EDT
Pacific Biosciences of California Employees
Pacific Biosciences of California had 485 employees as of December 31, 2025. The number of employees decreased by 90 or -15.65% compared to the previous year.
Employees
485
Change (1Y)
-90
Growth (1Y)
-15.65%
Revenue / Employee
$329,959
Profits / Employee
-$265,105
Market Cap
462.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -90 | -15.65% |
| Dec 31, 2024 | 575 | -221 | -27.76% |
| Dec 31, 2023 | 796 | 27 | 3.51% |
| Dec 31, 2022 | 769 | 41 | 5.63% |
| Dec 31, 2021 | 728 | 316 | 76.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,450 |
| Viemed Healthcare | 1,387 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 678 |
| OrthoPediatrics | 602 |
| Beta Bionics | 423 |
| Standard BioTools | 389 |
| NeuroPace | 220 |
PACB News
- 5 days ago - PacBio announces SPRQ-Nx chemistry now shipping worldwide - TheFly
- 5 days ago - PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing - GlobeNewsWire
- 10 days ago - Pacific Biosciences of California Proxy statement: Proxy filing - Filings
- 10 days ago - PacBio to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 12 days ago - Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology - Business Wire
- 20 days ago - HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss - GlobeNewsWire
- 21 days ago - PacBio price target raised to $1.50 from $1 at Barclays - TheFly
- 24 days ago - PacBio sees FY26 revenue $165M-$175M, consensus $174.42M - TheFly